Preventive Healthcare Services
Cancer Prevention
Cancer Prevention
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Healthcare Associated Infections II: Preventive Measures
Cancer Vaccines
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 25, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Alex Vosooney1, Catherine T Witkop, Amy G Cantor
1Allina Health Group, West St. Paul Clinic, West St. Paul, Minnesota; the Departments of Preventive Medicine and Gynecologic Surgery & Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland; the Departments of Medicine, Family Medicine, Obstetrics & Gynecology, and Pediatrics, Oregon Health & Sciences University, Portland, Oregon; the Department of Health Systems Science, Kaiser Permanente School of Medicine, Pasadena, the Keck University of Southern California School of Medicine and the Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, and KFF, San Francisco, California; the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, and the American College of Physicians, Philadelphia, Pennsylvania; the American College of Obstetricians & Gynecologists and the National Association of Nurse Practitioners in Women's Health, Washington, DC; UMass Chan Medical School / UMass Memorial Health, Shrewsbury, Massachusetts; the University of Arizona, Tucson, Arizona; and the American Academy of Family Physicians, Leawood, Kansas.
New cervical cancer screening guidelines now include patient-collected high-risk human papillomavirus (hrHPV) tests for average-risk women aged 30-65. This update aims to improve early detection of precancerous lesions and reduce screening barriers.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: